General
Australian managing partner of McKinsey regrets consultancy’s role during opioid epidemic
A damaging exposé has revealed how international consulting firm McKinsey & Company tried to pump up sales of an addictive painkiller during the opioid epidemic.
Key points:
- Consultancy firm McKinsey advised Purdue Pharma on how to increase the market share of its painkiller, OxyContin, at the height of the opioid crisis
- Its advice included offering rebates for OxyContin overdoses
- A McKinsey Australia spokesperson acknowledged a Zoom meeting was held after the revelations, saying it was part of a commitment to consider broader societal impacts of the firm’s work
After the news broke in The New York Times, the firm was in damage control and it sought to explain itself to its Australian workforce.
On a Monday earlier this month, Australian…
Continue Reading
-
Noosa News23 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
Noosa News14 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General8 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
General10 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for